Treace Benefits from Commercial Investments
The company grew by more than 52% in 3Q22, spurred by accelerating contributions from its direct sale force. Nov 14, 2022
Paragon 28 Growth Driven by New Product Cadence
The company grew over 28% in 3Q22, as new product introductions attract new surgeons and drive sales force expansions. Nov 14, 2022
Orthopedic Enabling Technology Startups Focused on Value
Orthopedic enabling technology startups are finding innovative ways to empower surgeons and improve healthcare economics. Nov 11, 2022
Vericel Reduces MACI Guide on Patient Flow Downturn
The company's MACI product grew nearly 30% in the third quarter of 2022, but patient flow disruptions brought a guidance reduction. Nov 11, 2022
Globus Stabilizes At High Single Digit Growth
The company grew just over 10% in third quarter of 2022, driven by competitive rep conversions and robotic pull-through. Nov 11, 2022
ATEC’s Sector-Leading Growth Validates Approach
The company grew over 40% in 3Q22, driven by its accelerating lateral surgery business and enabling technologies like EOS. Nov 09, 2022
Smith+Nephew Records Early Wins in Ortho Turnaround
Excluding the impact of foreign currency, the company grew in the mid-single digits as elective procedures recovered in the U.S. Nov 08, 2022
Orthofix’s Strategic Investments Driving Growth
The company grew in the mid-single digits at constant currency for 3Q22, driven by investments in its commercial channel. Nov 08, 2022
Enovis Continues Organic Growth Ramp
The company's reported orthopedic sales grew by nearly 20% in 3Q22, driven by double-digit growth across its product lines. Nov 07, 2022
Conformis Transformation Taking Longer Than Expected
The company declined in the low-single digits for 3Q22 as Conformis' business model transition meets roadblocks. Nov 07, 2022
